This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...